Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stinchcombe

Showing results (31-40 of 575) with videos related to

Pageof 58
Sort By:
Physical Review Letters|February 22, 1993
Jamming and kinetics of deposition-evaporation systems and associated quantum spin modelsBarma, Grynberg, Stinchcombe
Medical Oncology (Northwood, London, England)|April 22, 2014
Unmet needs in squamous cell carcinoma of the lung: potential role for immunotherapyThomas E Stinchcombe
F1000Prime Reports|January 13, 2015
Recent advances in the treatment of non-small cell and small cell lung cancerThomas E Stinchcombe
Translational Lung Cancer Research|December 13, 2024
Epidermal growth factor receptor exon 20 insertion mutations: are we getting closer to solving the puzzle?Thomas E Stinchcombe
Therapeutic Advances in Medical Oncology|August 13, 2020
Current management of <i>RET</i> rearranged non-small cell lung cancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2023
Flashback Foreword: Docetaxel Versus Best Supportive Care in Non-Small-Cell Lung Cancer and Pemetrexed Versus Docetaxel in Second-Line Non-Small-Cell Lung CancerThomas E Stinchcombe
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Novel formulations and new mechanisms of delivering chemotherapyThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2023
Flashback Foreword: Afatinib for the Treatment of Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung CancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2023
Flashback Foreword: Gefitinib in Non-Small-Cell Lung Cancer: The IDEAL 1 TrialThomas E Stinchcombe
Current Treatment Options in Oncology|March 11, 2016
The Use of EGFR Tyrosine Kinase Inhibitors in EGFR Wild-Type Non-Small-Cell Lung CancerThomas E Stinchcombe
Pageof 58

Showing results (31-40 of 575) with videos related to

Sort By:
Pageof 58
Physical Review Letters|February 22, 1993
Jamming and kinetics of deposition-evaporation systems and associated quantum spin modelsBarma, Grynberg, Stinchcombe
Medical Oncology (Northwood, London, England)|April 22, 2014
Unmet needs in squamous cell carcinoma of the lung: potential role for immunotherapyThomas E Stinchcombe
F1000Prime Reports|January 13, 2015
Recent advances in the treatment of non-small cell and small cell lung cancerThomas E Stinchcombe
Translational Lung Cancer Research|December 13, 2024
Epidermal growth factor receptor exon 20 insertion mutations: are we getting closer to solving the puzzle?Thomas E Stinchcombe
Therapeutic Advances in Medical Oncology|August 13, 2020
Current management of <i>RET</i> rearranged non-small cell lung cancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2023
Flashback Foreword: Docetaxel Versus Best Supportive Care in Non-Small-Cell Lung Cancer and Pemetrexed Versus Docetaxel in Second-Line Non-Small-Cell Lung CancerThomas E Stinchcombe
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Novel formulations and new mechanisms of delivering chemotherapyThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2023
Flashback Foreword: Afatinib for the Treatment of Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung CancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2023
Flashback Foreword: Gefitinib in Non-Small-Cell Lung Cancer: The IDEAL 1 TrialThomas E Stinchcombe
Current Treatment Options in Oncology|March 11, 2016
The Use of EGFR Tyrosine Kinase Inhibitors in EGFR Wild-Type Non-Small-Cell Lung CancerThomas E Stinchcombe
Pageof 58